NYSE:HR - Healthcare Realty Trust Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $31.89
  • Forecasted Upside: 2.37 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 4 Buy Ratings
  • 1 Strong Buy Ratings
$31.15
▲ +1.41 (4.74%)
1 month | 3 months | 12 months
Get New Healthcare Realty Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$31.89
▲ +2.37% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Healthcare Realty Trust in the last 3 months. The average price target is $31.89, with a high forecast of $43.00 and a low forecast of $25.00. The average price target represents a 2.37% upside from the last price of $31.15.
Buy
The current consensus among 9 investment analysts is to buy stock in Healthcare Realty Trust. This rating has held steady since July 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 1 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/30/2019
  • 1 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/28/2019
  • 1 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/26/2020
  • 1 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/25/2020
  • 1 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/24/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
10/22/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/21/2020
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/20/2021

Latest Recommendations

  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/13/2021Jefferies Financial GroupUpgradeHold ➝ Buy$30.00 ➝ $33.00High
i
9/18/2020Capital One FinancialUpgradeEqual Weight ➝ Overweight$33.00High
i
Rating by D. Bernstein at Capital One Financial Co.
9/1/2020Stifel NicolausReiterated RatingBuy$32.00Medium
i
8/31/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$34.00 ➝ $35.00Low
i
8/5/2020Capital One FinancialReiterated RatingEqual WeightLow
i
Rating by D. Bernstein at Capital One Financial Co.
7/2/2020CitigroupBoost Price TargetNeutral$29.00 ➝ $30.00Low
i
Rating by Michael Bilerman at Citigroup Inc.
4/29/2020Raymond JamesLower Price TargetOutperform$38.00 ➝ $34.00High
i
4/28/2020Wells Fargo & CompanyReiterated RatingHoldHigh
i
4/7/2020CitigroupDowngradeBuy ➝ Neutral$38.00 ➝ $29.00High
i
Rating by Michael Bilerman at Citigroup Inc.
4/3/2020Wells Fargo & CompanyLower Price TargetEqual Weight$33.00 ➝ $26.00Low
i
4/3/2020JPMorgan Chase & Co.Lower Price TargetNeutral$35.00 ➝ $30.00Low
i
3/26/2020Morgan StanleyLower Price TargetEqual Weight$33.00 ➝ $25.00High
i
3/12/2020Raymond JamesBoost Price TargetOutperform$36.00 ➝ $38.00High
i
3/9/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$35.00 ➝ $43.00High
i
2/13/2020BMO Capital MarketsReiterated RatingHold$35.00Low
i
12/20/2019MizuhoReiterated RatingNeutral$34.00Medium
i
12/12/2019CitigroupUpgradeNeutral ➝ Buy$34.00 ➝ $38.00Medium
i
Rating by Nicholas Joseph at Citigroup Inc.
11/26/2019Stifel NicolausUpgradeHold ➝ Buy$33.00 ➝ $35.00High
i
11/6/2019BMO Capital MarketsReiterated RatingHold$31.00Low
i
9/17/2019Morgan StanleyBoost Price TargetEqual Weight$31.00 ➝ $33.00Low
i
Rating by Vikram Malhorta at Morgan Stanley
9/12/2019Berenberg BankInitiated CoverageBuyLow
i
8/1/2019Capital One FinancialReiterated RatingEqual WeightLow
i
Rating by D. Bernstein at Capital One Financial Co.
6/20/2019CitigroupInitiated CoverageNeutral ➝ Neutral$34.00Low
i
5/13/2019Raymond JamesUpgradeMkt Perform ➝ Outperform$34.00Medium
i
3/28/2019Morgan StanleySet Price TargetHold$31.00Medium
i
Rating by Vikram Malhorta at Morgan Stanley
1/8/2019Raymond JamesUpgradeUnderperform ➝ Market PerformHigh
i
12/11/2018Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformMedium
i
11/13/2018MizuhoUpgradeNeutral ➝ Buy$32.00Low
i
10/18/2018Raymond JamesInitiated CoverageUnderperform ➝ UnderperformLow
i
8/16/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$29.00 ➝ $28.00High
i
8/13/2018MizuhoReiterated RatingHold$28.00Low
i
Rating by Richard Anderson at Mizuho
6/28/2018Capital One FinancialInitiated CoverageEqual Weight$30.00Low
i
Rating by D. Bernstein at Capital One Financial Co.
6/14/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$32.00 ➝ $29.00Low
i
4/24/2018Stifel NicolausDowngradeBuy ➝ Hold$30.00 ➝ $28.00High
i
4/2/2018MizuhoReiterated RatingHold$27.00Medium
i
3/27/2018BMO Capital MarketsReiterated RatingHold$31.00Low
i
Rating by John Kim at BMO Capital Markets
3/20/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$35.00 ➝ $32.00High
i
3/16/2018Cantor FitzgeraldLower Price TargetOverweight$34.00Low
i
2/23/2018MizuhoReiterated RatingHold$29.00Low
i
2/16/2018BMO Capital MarketsReiterated RatingHold$32.00Medium
i
2/15/2018SunTrust BanksSet Price TargetHold$30.00Low
i
Rating by Eric Fleming at SunTrust Banks, Inc.
2/15/2018Stifel NicolausLower Price TargetBuy ➝ Buy$34.00 ➝ $30.00Low
i
2/14/2018Cantor FitzgeraldReiterated RatingBuy$38.00Low
i
1/22/2018SunTrust BanksSet Price TargetHold$32.00Low
i
Rating by Eric Fleming at SunTrust Banks, Inc.
1/9/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$33.00N/A
i
12/22/2017KeyCorpReiterated RatingEqual WeightLow
i
Rating by Jordan Sadler at KeyCorp
12/14/2017Morgan StanleyReiterated RatingOverweight$34.00Low
i
11/5/2017MizuhoReiterated RatingHold$34.00N/A
i
11/3/2017Stifel NicolausReiterated RatingBuy$34.00N/A
i
11/2/2017BMO Capital MarketsReiterated RatingBuy$34.00N/A
i
10/29/2017KeyCorpSet Price TargetSell$25.00N/A
i
10/27/2017MizuhoReiterated RatingHold$35.00N/A
i
10/2/2017BMO Capital MarketsReiterated RatingBuy$34.00Low
i
9/26/2017KeyCorpReiterated RatingSell$25.00Low
i
9/25/2017Morgan StanleyBoost Price TargetOverweight$32.50 ➝ $34.00Low
i
8/24/2017KeyCorpReiterated RatingSell$25.00Low
i
8/23/2017Cantor FitzgeraldReiterated RatingBuyLow
i
8/15/2017Cantor FitzgeraldReiterated RatingBuy$38.00Low
i
8/10/2017Jefferies Financial GroupReiterated RatingHold$36.00 ➝ $34.00Low
i
8/4/2017Stifel NicolausReiterated RatingBuyLow
i
7/17/2017Jefferies Financial GroupReiterated RatingHold$36.00Low
i
6/28/2017MizuhoReiterated RatingNeutralLow
i
6/15/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$36.00Low
i
6/12/2017Cantor FitzgeraldBoost Price TargetBuy$35.00 ➝ $38.00Medium
i
5/12/2017Jefferies Financial GroupReiterated RatingBuy$36.00Medium
i
5/9/2017Stifel NicolausLower Price TargetBuy$34.00 ➝ $33.00Low
i
3/15/2017BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$31.00 ➝ $33.00High
i
2/20/2017DesjardinsReiterated RatingBuyN/A
i
Rating by M. Markidis at Desjardins
1/31/2017Cantor FitzgeraldUpgradeHold ➝ BuyN/A
i
12/22/2016BMO Capital MarketsInitiated CoverageMarket Perform$31.00N/A
i
12/21/2016KeyCorpDowngradeUnderweightN/A
i
12/16/2016Jefferies Financial GroupInitiated CoverageBuyN/A
i
12/15/2016KeyCorpDowngradeSector Weight ➝ UnderweightN/A
i
12/13/2016Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformN/A
i
11/30/2016Cantor FitzgeraldReiterated RatingBuy$35.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
11/14/2016Cantor FitzgeraldUpgradeHold ➝ Buy$37.00 ➝ $35.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
11/4/2016JMP SecuritiesUpgradeUnderperform ➝ Market PerformN/A
i
9/9/2016Cantor FitzgeraldReiterated RatingHoldN/A
i
Rating by Joseph France at Cantor Fitzgerald
9/4/2016Wells Fargo & CompanyReiterated RatingHoldN/A
i
8/25/2016BTIG ResearchInitiated CoverageNeutralN/A
i
8/22/2016Royal Bank of CanadaReiterated RatingHoldN/A
i
8/8/2016MizuhoBoost Price TargetNeutral$29.00 ➝ $34.00N/A
i
8/4/2016Stifel NicolausBoost Price TargetBuy$34.00 ➝ $36.00N/A
i
6/23/2016Cantor FitzgeraldInitiated CoverageHold$37.00N/A
i
Rating by Sahar Wolff at Cantor Fitzgerald
6/22/2016JMP SecuritiesDowngradeMarket Perform ➝ Underperform$29.00N/A
i
5/5/2016Stifel NicolausBoost Price TargetBuy$31.00 ➝ $34.00N/A
i
Rating by Daniel Bernstein at Stifel Nicolaus
3/23/2016CowenUpgradeUnderperform ➝ Market Perform$29.00N/A
i
2/22/2016MizuhoDowngradeBuy ➝ Neutral$29.00N/A
i
2/19/2016Royal Bank of CanadaBoost Price TargetSector Perform$27.00 ➝ $29.00N/A
i
(Data available from 1/20/2016 forward)
Healthcare Realty Trust logo
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.
Read More

Today's Range

Now: $31.15
$29.72
$31.17

50 Day Range

MA: $29.44
$28.15
$30.23

52 Week Range

Now: $31.15
$24.10
$37.97

Volume

1,095,104 shs

Average Volume

1,093,583 shs

Market Capitalization

$4.24 billion

P/E Ratio

36.65

Dividend Yield

4.03%

Beta

0.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthcare Realty Trust?

The following Wall Street analysts have issued research reports on Healthcare Realty Trust in the last twelve months: BMO Capital Markets, Capital One Financial Co., Citigroup Inc., Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Raymond James, Stifel Nicolaus, TheStreet, Wells Fargo & Company, and Zacks Investment Research.

What is the current price target for Healthcare Realty Trust?

9 Wall Street analysts have set twelve-month price targets for Healthcare Realty Trust in the last year. Their average twelve-month price target is $31.89, suggesting a possible upside of 3.0%. BMO Capital Markets has the highest price target set, predicting HR will reach $43.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $25.00 for Healthcare Realty Trust in the next year.

What is the current consensus analyst rating for Healthcare Realty Trust?

Healthcare Realty Trust currently has 4 hold ratings, 4 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HR will outperform the market and that investors should add to their positions of Healthcare Realty Trust.

What other companies compete with Healthcare Realty Trust?

How do I contact Healthcare Realty Trust's investor relations team?

Healthcare Realty Trust's physical mailing address is 3310 WEST END AVE SUITE 700, NASHVILLE TN, 37203. The real estate investment trust's listed phone number is 615-269-8175 and its investor relations email address is communications@healthcarerealty.com. The official website for Healthcare Realty Trust is www.healthcarerealty.com.